Nafamostat Mesylate
£65.00 10mg
Serine protease inhibitor.
Nafamostat mesylate is a serine protease inhibitor. It inhibits a large number of Lys/Arg specific serine proteinases, and is also a tryptase inhibitor. In vivo nafamostat is a fast-acting proteolytic inhibitor and used during hemodialysis to prevent the proteolysis of fibrinogen into fibrin. Nafamostat also has some antiviral and anti-cancer properties and has been identified as a potential treatment for COVID-19.
Please contact us for availability.
Additional information
Three Letter Sequence | 4-[(Aminoiminomethyl)amino]benzoic acid 6-(aminoiminomethyl)-2-naphthalenyl ester dimethanesulfonate |
---|---|
Molecular Weight | 539.59 |
Molecular Formula | C19H17N5O2.2CH4O3S |
Sequence | 4-[(Aminoiminomethyl)amino]benzoic acid 6-(aminoiminomethyl)-2-naphthalenyl ester dimethanesulfonate |
Solubility | Soluble to 100 mM in water |
Appearance | White solid |
Storage | Store desiccated, frozen and in the dark |
Purity | >98% by HPLC |